Next-generation probiotics – do they open new therapeutic strategies for cancer patients?
Karolina Kaźmierczak-Siedlecka, Karolina Skonieczna‐Żydecka, Theodore Hupp, Renata Duchnowska, Natalia Marek-Trzonkowska, Karol Połom
Abstract
strains provide a beneficial effect to the host, are non-toxigenic and considered as the best current NGP candidate. Overall, emerging studies indicate a beneficial role of these NGPs in the prevention of carcinogenesis and open new promising therapeutic options for cancer patients.
Topics & Concepts
Akkermansia muciniphilaBiologyFaecalibacterium prausnitziiCancerBacteroides fragilisColorectal cancerGut floraImmunologyCarcinogenesisCancer preventionCancer researchMicrobiologyAntibioticsGeneticsGut microbiota and healthProbiotics and Fermented FoodsClostridium difficile and Clostridium perfringens research